Sign In

Login

Password

Forgot Password ? Sign Up

Infliximab (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Infliximab" in Czech language version.

refsWebsite
Global rank Czech rank
5sukl.cz
low place
373rd place
4doi.org
2nd place
4th place
3worldcat.org
5th place
3rd place
2elsevier.com
610th place
203rd place
1cuni.cz
3,645th place
32nd place
1wiley.com
222nd place
83rd place

cuni.cz (Global: 3,645th place; Czech: 32nd place)

sfx.is.cuni.cz

  • SFX by Ex Libris Inc.. sfx.is.cuni.cz [online]. [cit. 2018-02-18]. Dostupné online. 

doi.org (Global: 2nd place; Czech: 4th place)

  • CORNILLIE, Freddy. Ten years of infliximab (Remicade®) in clinical practice: The story from bench to bedside. European Journal of Pharmacology. Roč. 623, s. S1–S4. Dostupné online [cit. 2018-02-18]. doi:10.1016/j.ejphar.2009.10.023. 
  • ISHIGATSUBO, Y.; TAKENO, M.; KIRINO, Y. Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis. Pediatric Rheumatology. 2015-09-28, roč. 13, čís. 1, s. P166. Dostupné online [cit. 2018-02-18]. ISSN 1546-0096. doi:10.1186/1546-0096-13-s1-p166. 
  • DJOKANOVIC, Nada; KLIEGER-GROSSMANN, Chagit; PUPCO, Anna. Safety of infliximab use during pregnancy. Reproductive Toxicology. Roč. 32, čís. 1, s. 93–97. Dostupné online [cit. 2018-02-18]. doi:10.1016/j.reprotox.2011.05.009. 
  • SINGH, S.; ANDERSEN, N. N.; ANDERSSON, M. Comparison of infliximab with adalimumab in 827 biologic-naïve patients with Crohn's disease: a population-based Danish cohort study. Alimentary Pharmacology & Therapeutics. 2018-03-01, roč. 47, čís. 5, s. 596–604. Dostupné online [cit. 2018-02-18]. ISSN 1365-2036. doi:10.1111/apt.14466. (anglicky) 

elsevier.com (Global: 610th place; Czech: 203rd place)

linkinghub.elsevier.com

sukl.cz (Global: low place; Czech: 373rd place)

  • S.R.O., QCM. REMICADE, 100MG INF PLV CSL 1, Státní ústav pro kontrolu léčiv. www.sukl.cz [online]. [cit. 2018-02-18]. Dostupné online. 
  • S.R.O., QCM. INFLECTRA, 100MG INF PLV CSL 1, Státní ústav pro kontrolu léčiv. www.sukl.cz [online]. [cit. 2018-02-18]. Dostupné online. 
  • S.R.O., QCM. REMSIMA, 100MG INF PLV CSL 1, Státní ústav pro kontrolu léčiv. www.sukl.cz [online]. [cit. 2018-02-18]. Dostupné online. 
  • S.R.O., QCM. FLIXABI, 100MG INF PLV CSL 1, Státní ústav pro kontrolu léčiv. www.sukl.cz [online]. [cit. 2018-02-18]. Dostupné online. 
  • S.R.O., QCM. HUMIRA, 40MG INJ SOL 2X0,8ML I, Státní ústav pro kontrolu léčiv. www.sukl.cz [online]. [cit. 2018-02-18]. Dostupné online. 

wiley.com (Global: 222nd place; Czech: 83rd place)

onlinelibrary.wiley.com

  • SINGH, S.; ANDERSEN, N. N.; ANDERSSON, M. Comparison of infliximab with adalimumab in 827 biologic-naïve patients with Crohn's disease: a population-based Danish cohort study. Alimentary Pharmacology & Therapeutics. 2018-03-01, roč. 47, čís. 5, s. 596–604. Dostupné online [cit. 2018-02-18]. ISSN 1365-2036. doi:10.1111/apt.14466. (anglicky) 

worldcat.org (Global: 5th place; Czech: 3rd place)

  • 1949-, Hořejší, Václav,. Základy imunologie. 6., aktualizované vydání. vyd. V Praze: [s.n.] 297 s. ISBN 9788075532503. OCLC 989928270 
  • ISHIGATSUBO, Y.; TAKENO, M.; KIRINO, Y. Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis. Pediatric Rheumatology. 2015-09-28, roč. 13, čís. 1, s. P166. Dostupné online [cit. 2018-02-18]. ISSN 1546-0096. doi:10.1186/1546-0096-13-s1-p166. 
  • SINGH, S.; ANDERSEN, N. N.; ANDERSSON, M. Comparison of infliximab with adalimumab in 827 biologic-naïve patients with Crohn's disease: a population-based Danish cohort study. Alimentary Pharmacology & Therapeutics. 2018-03-01, roč. 47, čís. 5, s. 596–604. Dostupné online [cit. 2018-02-18]. ISSN 1365-2036. doi:10.1111/apt.14466. (anglicky)